How to Buy Adderall (Amphetamine Salts) Online
- What Adderall is and its four active amphetamine ingredients
- How it works (dopamine and norepinephrine mechanism)
- FDA schedule and controlled substance classification
- Immediate-release (IR) vs. extended-release (XR) comparison
- FDA-approved uses: ADHD and narcolepsy
- Dosage ranges and administration
- Common and serious side effects
- Drug interactions, contraindications, and precautions
- Personalized medical advice or treatment recommendations
- Specific dosing for your individual condition
- Information about purchasing medications
- Alternatives to prescribed treatments (consult your provider)
On This Page
What Is Adderall?
Adderall is the brand name for a combination of four amphetamine salt forms used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy. It is classified as a central nervous system (CNS) stimulant.
First approved by the FDA in 1996, Adderall is one of the most commonly prescribed medications for ADHD in the United States. It is available in both immediate-release (Adderall IR) and extended-release (Adderall XR) formulations, as well as a long-acting prodrug formulation (Vyvanse/lisdexamfetamine, which is a separate product).
Adderall works primarily by increasing the activity of dopamine and norepinephrine in the prefrontal cortex — brain regions responsible for attention, focus, and impulse control. This mechanism helps improve attention span, reduce hyperactivity, and decrease impulsive behavior in individuals with ADHD.
Active Ingredients
Each Adderall tablet contains a fixed-dose combination of four amphetamine salts:
| Ingredient | Type | Role |
|---|---|---|
| Amphetamine aspartate | Levoamphetamine salt | Provides peripheral sympathetic effects and contributes to therapeutic activity |
| Amphetamine sulfate | Racemic (D/L) salt | Contains both dextroamphetamine and levoamphetamine; provides balanced central and peripheral effects |
| Dextroamphetamine saccharate | Dextroamphetamine salt | Primary active enantiomer responsible for central dopamine and norepinephrine effects |
| Dextroamphetamine sulfate | Dextroamphetamine salt | Most potent CNS-active component; primary driver of therapeutic efficacy |
The combination of these four salts produces both rapid-onset and sustained amphetamine blood levels. Dextroamphetamine is the more pharmacologically active enantiomer for CNS effects, while levoamphetamine contributes more to peripheral effects such as cardiovascular stimulation.
How Adderall Works
Adderall's therapeutic effects are mediated through two primary mechanisms in the brain:
Dopamine Enhancement
Amphetamines increase dopamine levels in the synaptic cleft by:
- Releasing stored dopamine from presynaptic vesicles into the synapse
- Blocking dopamine reuptake by inhibiting the dopamine transporter (DAT)
- Inhibiting monoamine oxidase (MAO), reducing the enzymatic breakdown of dopamine
In the prefrontal cortex — the brain region responsible for executive function, attention, and impulse control — increased dopamine activity improves the signal-to-noise ratio of neural signaling, allowing better focus and reduced distractibility.
Norepinephrine Enhancement
Similarly, amphetamines increase norepinephrine levels by:
- Promoting norepinephrine release from presynaptic neurons
- Blocking norepinephrine reuptake via the norepinephrine transporter (NET)
Enhanced norepinephrine activity in the prefrontal cortex further supports attention, alertness, and working memory.
In individuals with ADHD, baseline levels of dopamine and norepinephrine in the prefrontal cortex are thought to be suboptimal. Amphetamines help restore adequate neurotransmitter levels in this region, improving attention and reducing hyperactive and impulsive behaviors.
FDA Schedule & Classification
| Drug Name | Adderall (mixed amphetamine salts) |
|---|---|
| Drug Class | Central Nervous System Stimulant (Amphetamine) |
| DEA Schedule | Schedule II (C-II) |
| Controlled Substance Act | High potential for abuse which may lead to severe psychological or physical dependence. Accepted medical use with severe restrictions. |
| Prescription Required | Yes — written prescription required (no refills; new prescription needed each time in most states) |
| FDA Approval | 1996 (Adderall IR), 2000 (Adderall XR) |
| Availability | Generic (mixed amphetamine salts) and brand-name (Adderall, Adderall XR) |
As a Schedule II controlled substance, Adderall has a higher regulatory burden than Schedule IV drugs like Xanax or Ambien. Prescriptions must be written (no phone-in or electronic refills in most states), quantity limits may apply, and pharmacies maintain stricter records.
IR vs. XR Comparison
| Feature | Adderall IR | Adderall XR |
|---|---|---|
| Formulation | Immediate-release tablet | Extended-release capsule (beaded formulation) |
| Onset of action | 20—60 minutes | 1—2 hours |
| Peak effect | 2—3 hours | 5—7 hours |
| Duration | 4—6 hours | 10—12 hours |
| Dosing frequency | 2—3 times daily | Once daily |
| Available strengths | 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg, 20 mg, 30 mg | 5 mg, 10 mg, 15 mg, 20 mg, 25 mg, 30 mg |
| Best for | Flexible dosing, afternoon coverage, titration | All-day coverage, once-daily convenience, school/work |
| Crushing/dividing | Can be divided for dose adjustment | Do not crush, chew, or open — defeats extended-release mechanism |
The choice between IR and XR depends on the individual's daily schedule, symptom pattern, tolerance, and clinician preference. Many patients start with IR for dose titration and then transition to XR for convenience once an optimal dose is determined.
FDA-Approved Uses
Attention Deficit Hyperactivity Disorder (ADHD)
Adderall is FDA-approved for the treatment of ADHD in patients aged 3 years and older. ADHD is characterized by persistent patterns of inattention, hyperactivity, and impulsivity that interfere with daily functioning. Amphetamines are considered a first-line pharmacological treatment for ADHD, particularly for patients who do not respond adequately to methylphenidate-based medications.
Narcolepsy
Adderall is FDA-approved for the treatment of narcolepsy — a chronic neurological disorder characterized by excessive daytime sleepiness, cataplexy (sudden muscle weakness triggered by emotions), sleep paralysis, and hypnagogic hallucinations. Amphetamines promote wakefulness by increasing dopaminergic and noradrenergic activity in wake-promoting brain regions.
Dosage & Administration
Adderall IR (Immediate-Release)
| Patient Group | Starting Dose | Titration | Maximum Daily Dose |
|---|---|---|---|
| Children (6+ years) | 5 mg once or twice daily | Increase by 5 mg weekly | 40 mg/day |
| Adolescents | 5 mg once or twice daily | Increase by 5 mg weekly | 40 mg/day |
| Adults | 5 mg once or twice daily | Increase by 5 mg weekly | 60 mg/day |
Adderall XR (Extended-Release)
| Patient Group | Starting Dose | Titration | Maximum Daily Dose |
|---|---|---|---|
| Children (6+ years) | 10 mg once daily | Increase by 10 mg weekly | 30 mg/day |
| Adolescents | 10 mg once daily | Increase by 10 mg weekly | 30 mg/day |
| Adults | 20 mg once daily | Increase by 10 mg weekly | 60 mg/day |
Administration tips:
- Take Adderall in the morning to minimize insomnia
- Take XR with or without food — high-fat meals may delay absorption
- Swallow XR capsules whole — do not crush, chew, or open
- A dose taken after noon may interfere with sleep
- Elderly patients may require lower starting doses
Side Effects
Common Side Effects
These are the most frequently reported side effects of amphetamine-based stimulants:
- Decreased appetite and weight loss — the most common side effect; monitor growth in children
- Insomnia / difficulty falling asleep — take last dose before early afternoon
- Dry mouth (xerostomia)
- Headache
- Anxiety and nervousness
- Increased heart rate (tachycardia)
- Elevated blood pressure
- Jaw clenching / teeth grinding (bruxism)
- Stomach pain and nausea
- Mood swings and irritability
- Dizziness
Serious Side Effects
Contact your healthcare provider or seek emergency medical attention if you experience:
- Cardiovascular events: Chest pain, shortness of breath, fainting, irregular heartbeat — especially in patients with pre-existing heart conditions
- Psychiatric symptoms: Hallucinations, mania, aggression, suicidal thoughts or behavior, new or worsening anxiety or depression
- Serotonin syndrome: Agitation, hallucinations, rapid heart rate, fever, muscle rigidity, nausea, vomiting — especially when combined with serotonergic medications
- Peripheral vasculopathy: Raynaud's phenomenon (cold, painful fingers/toes), color changes in extremities
- Priapism: Prolonged, painful erection (medical emergency in males)
- Growth suppression: In children, monitor height and weight regularly
- Seizures: May lower seizure threshold in susceptible individuals
Drug Interactions
Major Interactions (Avoid or Use Extreme Caution)
- Monoamine oxidase inhibitors (MAOIs): Selegiline, rasagiline, phenelzine, tranylcypromine — concurrent use can cause hypertensive crisis (dangerously high blood pressure). Allow at least 14 days between MAOI discontinuation and Adderall initiation.
- Acidifying agents: Ammonium chloride, sodium acid phosphate, ascorbic acid (vitamin C) — may increase amphetamine excretion and reduce efficacy
- Alkalinizing agents: Sodium bicarbonate, antacids — may decrease amphetamine excretion and increase toxicity
- Serotonergic drugs: SSRIs, SNRIs, triptans, tramadol, tryptophan — risk of serotonin syndrome
Moderate Interactions (Monitor Closely)
- Tricyclic antidepressants (TCAs): May potentiate cardiovascular effects of amphetamines
- Blood pressure medications: Amphetamines may reduce the effectiveness of antihypertensives
- Antacids and urinary alkalinizers: May increase amphetamine absorption and half-life
- Antihistamines: May counteract the wake-promoting effects of amphetamines
- Phenobarbital and phenytoin: May affect seizure threshold in combination
Food Interactions
- Acidic foods and beverages (citrus juices, vitamin C) may reduce absorption
- High-fat meals may delay absorption of Adderall XR
- Caffeine — additive stimulant effects; limit intake while on Adderall
Contraindications & Precautions
Contraindications
Adderall is contraindicated (should not be used) in patients with:
- Known hypersensitivity to amphetamine or any formulation component
- Concurrent use of MAOIs or within 14 days of MAOI discontinuation
- Advanced arteriosclerosis (hardening of the arteries)
- Symptomatic cardiovascular disease — including coronary artery disease, heart failure, cardiomyopathy, arrhythmias
- Moderate to severe hypertension (high blood pressure)
- Hyperthyroidism (overactive thyroid)
- Glaucoma (increased intraocular pressure)
- History of drug abuse or dependence
- Agitated states or severe anxiety
Precautions
- Cardiovascular monitoring: Baseline and periodic blood pressure and heart rate checks recommended
- Psychiatric monitoring: Monitor for emergence or worsening of anxiety, depression, mania, or psychotic symptoms
- Substance use history: Use with caution and close monitoring in patients with a history of substance use disorder
- Pregnancy: FDA Pregnancy Category C — use only if potential benefit justifies potential risk to the fetus. Neonatal withdrawal symptoms possible.
- Breastfeeding: Amphetamines pass into breast milk. Generally not recommended during stimulant use.
- Growth monitoring: In pediatric patients, monitor height and weight at each visit. appetite suppression may affect growth.
- Seizure disorder: Use with caution — may lower seizure threshold
Cited Sources
- FDA — Adderall (Mixed Amphetamine Salts) Prescribing Information (AccessData, FDA)
- MedlinePlus — Amphetamine and Dextroamphetamine (National Library of Medicine)
- DailyMed — Adderall Label (National Library of Medicine)
- DEA — Controlled Substance Schedules
- StatPearls — Amphetamine (National Center for Biotechnology Information)